Auto-Injectors Market Size, Share, & Trends Analysis By Product Type (Disposable, Reusable), By Disease Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis), By End Use (Homecare Settings, Hospitals & Clinics), And Segment Forecasts, 2019 - 2026

Published: Aug, 2019 | Pages: 100 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global auto-injectors market size is expected to reach USD 3.18 billion by 2026, according to a new report by Grand View Research, Inc, exhibiting a CAGR of 19.5%. Rising incidence of anaphylactic shock and other diseases such as diabetes, rheumatoid, & multiple sclerosis along with increasing approvals of auto-injectors are impelling growth.

Increasing prevalence of life-threatening allergies and rising demand for these devices are expected to aid growth. As per the Food Allergy Research & Education, around 200, 000 people every year need emergency medical care for allergic food reactions.

In addition, increasing approvals are anticipated to drive growth. For instance, in August 2018, U.S. FDA approved the first generic epinephrine auto-injector of Teva Pharmaceuticals to treat emergency allergic reactions, including anaphylaxis. Generic versions of EpiPen Jr & EpiPen of 0.15 mg & 0.3 mg, respectively, are indicated for pediatric and adult patients weighing more than 33 pounds.

Moreover, manufacturers are also developing new products and innovative technologies, which is expected to propel market growth. For instance, in June 2018, AbbVie GK launched Humira, which is a fully human antitumor necrosis factor alpha monoclonal antibody formulation with lock function & injection start & end alerts as well as an inspection window and injects completely in 10 seconds. Demand for these devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are anticipated to make them more convenient and user-friendly. This is encouraging patients to adopt this technology for chronic illnesses.

Further key findings from the report suggest:

• Disposable auto-injectors emerged as the largest segment owing to convenience and ease of use

• Homecare settings accounted for largest share in end-use segment owing to increasing demand of products for daily administration of insulin

• North America dominated the auto-injectors market with largest share in 2018. Increasing demand for new technologies along with advanced healthcare infrastructure is expected to boost market growth during the forecast period

• Asia Pacific is expected to witness fastest growth during the forecast period owing to increasing number of diabetic patients

• Some of the key players are Eli Lilly; Scandinavian Health Ltd.; AbbVie, Inc.; Amgen; Owen Mumford; Ypsomed; Teva Pharmaceutical; Biogen Idec; Mylan N.V.; Pfizer, Inc.; and Sanofi

 Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Product type
                        1.1.2. Disease indication
                        1.1.3. Regional scope
                        1.1.4. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR's internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                            1.6.1.1. Approach 1: Commodity flow approach
                        1.6.2. Volume price analysis (Model 2)
                            1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                        1.9.1. Objective 1
                        1.9.2. Objective 2
                        1.9.3. Objective 3
                        1.9.4. Objective 4
Chapter 2. Executive Summary
                    2.1. Market Outlook 
                    2.2. Segment Outlook 
                    2.3. Competitive Insights 
Chapter 3. Auto-injectors Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Product Pipeline Analysis, by Stage
                    3.4. Market Dynamics
                        3.4.1. Market driver analysis
                            3.4.1.1. Growing prevalence of targeted therapies
                            3.4.1.2. Increase in the incidence of anaphylactic shock
                            3.4.1.3. Patients preference to choose self-administration of injections
                        3.4.2. Market restraint analysis
                            3.4.2.1. Availability of its substitute products like general injections and oral tablets
                        3.4.3. Industry challenges 
                    3.5. Auto-injectors : Market Analysis Tools
                        3.5.1. Industry analysis - Porter's
                            3.5.1.1. Supplier power
                            3.5.1.2. Buyer power
                            3.5.1.3. Substitution threat
                            3.5.1.4. Threat from new entrant
                            3.5.1.5. Competitive rivalry 
                        3.5.2. PESTEL analysis
                            3.5.2.1. Political landscape
                            3.5.2.2. Environmental landscape
                            3.5.2.3. Social landscape
                            3.5.2.4. Technology landscape
                            3.5.2.5. Legal landscape
                        3.5.3. Major deals & strategic alliances analysis 
Chapter 4. Auto-injectors Market: Segment Analysis, by Product Type, 2015 - 2026 (USD Million)
                    4.1. Definitions & Scope
                    4.2. Product Type Market Share Analysis, 2018 & 2026
                    4.3. Segment Dashboard
                    4.4. Global Auto-injectors Market, by Product Type, 2015 to 2026
                    4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 
                        4.5.1. Disposable auto-injectors 
                        4.5.2. Reusable auto-injectors
                            4.5.2.1. Prefilled
                            4.5.2.2. Empty
Chapter 5. Auto-injectors Market: Segment Analysis, by Disease Indication Type, 2015 - 2026 (USD Million)
                    5.1. Definitions & Scope
                    5.2. Disease Indication Type Market Share Analysis, 2018 & 2026
                    5.3. Segment Dashboard
                    5.4. Global Auto-injectors Market, by Product Type, 2015 to 2026
                    5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 
                        5.5.1. Rheumatoid arthritis 
                        5.5.2. Multiple sclerosis 
                        5.5.3. Diabetes 
                        5.5.4. Anaphylaxis 
                        5.5.5. Other therapies
Chapter 6. Auto-Injectors Market: Segment Analysis, By End-use, 2015 - 2026 (USD Million)
                    6.1. Definitions & Scope
                    6.2. End-use market share analysis, 2018 & 2026
                    6.3. Segment Dashboard
                    6.4. Global Auto-Injectors Market, by End-use, 2015 to 2026
                    6.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following 
                        6.5.1. Home Care Settings
                        6.5.2. Hospitals & Clinics 
                        6.5.3. Ambulatory Surgical Centers
Chapter 7. Auto-injectors Market: Regional Market Analysis, by Product Type, 2015 - 2026 (USD Million)
                    7.1. Definitions & Scope
                    7.2. Regional Market Share Analysis, 2018 & 2026
                    7.3. Regional Market Dashboard
                    7.4. Regional Market Snapshot
                    7.5. Regional Market Share, 2018
                    7.6. Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
                    7.7. North America
                        7.7.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                        7.7.2. Market estimates and forecast, By product type, 2015 - 2026 (USD Million)
                        7.7.3. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                        7.7.4. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.7.5. U.S.
                            7.7.5.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million) 
                            7.7.5.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.7.5.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.7.6. Canada
                            7.7.6.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.7.6.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.7.6.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                    7.8. Europe
                        7.8.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                        7.8.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                        7.8.3. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                        7.8.4. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.8.5. Germany
                            7.8.5.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.8.5.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.8.5.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.8.6. U.K.
                            7.8.6.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.8.6.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.8.6.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.8.7. France
                            7.8.7.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.8.7.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.8.7.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.8.8. Italy
                            7.8.8.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.8.8.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.8.8.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.8.9. Spain
                            7.8.9.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.8.9.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.8.9.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                    7.9. Asia Pacific
                        7.9.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                        7.9.2. Market estimates and forecast, By product type, 2015 - 2026 (USD Million)
                        7.9.3. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                        7.9.4. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.9.5. China
                            7.9.5.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.9.5.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.9.5.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.9.6. Japan
                            7.9.6.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.9.6.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.9.6.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.9.7. India
                            7.9.7.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.9.7.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.9.7.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.9.8. Australia
                            7.9.8.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.9.8.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.9.8.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.9.9. South Korea
                            7.9.9.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.9.9.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.9.9.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                    7.10. Latin America
                        7.10.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                        7.10.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                        7.10.3. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                        7.10.4. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.10.5. Brazil
                            7.10.5.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.10.5.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.10.5.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.10.6. Mexico
                            7.10.6.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.10.6.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.10.6.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.10.7. Argentina 
                            7.10.7.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.10.7.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.10.7.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.10.8. Colombia
                            7.10.8.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.10.8.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.10.8.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                    7.11. Middle East and Africa
                        7.11.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                        7.11.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                        7.11.3. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                        7.11.4. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.11.5. South Africa
                            7.11.5.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.11.5.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.11.5.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.11.6. Saudi Arabia
                            7.11.6.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.11.6.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.11.6.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
                        7.11.7. UAE
                            7.11.7.1. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                            7.11.7.2. Market estimates and forecast, by disease indication type, 2015 - 2026 (USD Million)
                            7.11.7.3. Market estimates and forecast, by end-use, 2015 - 2026 (USD Million)
Chapter 8. Auto-injectors Market - Competitive Analysis
                    8.1. Key Company Profiles
                        8.1.1. Eli Lilly
                            8.1.1.1. Company overview
                            8.1.1.2. Financial performance
                            8.1.1.3. Product benchmarking
                            8.1.1.4. Strategic initiatives
                        8.1.2. Biogen Idec
                            8.1.2.1. Company overview
                            8.1.2.2. Financial performance
                            8.1.2.3. Product benchmarking
                            8.1.2.4. Strategic initiatives
                        8.1.3. Pfizer, Inc.
                            8.1.3.1. Company overview
                            8.1.3.2. Financial performance
                            8.1.3.3. Product benchmarking
                            8.1.3.4. Strategic initiatives
                        8.1.4. Mylan N.V.
                            8.1.4.1. Company overview
                            8.1.4.2. Financial performance
                            8.1.4.3. Product benchmarking
                            8.1.4.4. Strategic initiatives
                        8.1.5. Sanofi
                            8.1.5.1. Company overview
                            8.1.5.2. Financial performance
                            8.1.5.3. Product benchmarking
                            8.1.5.4. Strategic initiatives
                        8.1.6. Owen Mumford
                            8.1.6.1. Company overview
                            8.1.6.2. Financial performance
                            8.1.6.3. Product benchmarking
                            8.1.6.4. Strategic initiatives
                        8.1.7. Teva Pharmaceutical
                            8.1.7.1. Company overview
                            8.1.7.2. Financial performance
                            8.1.7.3. Product benchmarking
                            8.1.7.4. Strategic initiatives
                        8.1.8. Amgen
                            8.1.8.1. Company overview
                            8.1.8.2. Financial performance
                            8.1.8.3. Product benchmarking
                            8.1.8.4. Strategic initiatives
                        8.1.9. Ypsomed
                            8.1.9.1. Company overview
                            8.1.9.2. Financial performance
                            8.1.9.3. Product benchmarking
                            8.1.9.4. Strategic initiatives
                        8.1.10. Abbvie
                            8.1.10.1. Company overview
                            8.1.10.2. Financial performance
                            8.1.10.3. Product benchmarking
                            8.1.10.4. Strategic initiatives
                        8.1.11. Scandinavian Health Ltd.
                            8.1.11.1. Company overview
                            8.1.11.2. Financial performance
                            8.1.11.3. Product benchmarking
                            8.1.11.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Global Auto-injectors Market, by Region, 2015 - 2026 (USD Million)
Table 4 Global Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 5 Global Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 6 Global Auto-injectors Market, by Reusable auto-injectors 2015 - 2026 (USD Million)
Table 7 Global Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 8 North America Auto-injectors Market, by Country, 2015 - 2026 (USD Million)
Table 9 North America Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 10 North America Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 11 North America Auto-injectors Market, by reusable auto-injectors, 2015 - 2026 (USD Million) 
Table 12 North America Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 13 U.S. Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 14 U.S. Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 15 U.S. Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 16 U.S. Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 17 Canada Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 18 Canada Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 19 Canada Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 20 Canada Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 21 Europe Auto-injectors Market, by Country, 2015 - 2026 (USD Million)
Table 22 Europe Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 23 Europe Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 24 Europe Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 25 Europe Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 26 U.K. Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 27 U.K. Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 28 U.K. Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 29 U.K. Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 30 Germany Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 31 Germany Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 32 Germany Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 33 Germany Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 34 France Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 35 France Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 36 France Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 37 France Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 38 Italy Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 39 Italy Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 40 Italy Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 41 Italy Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 42 Spain Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 43 Spain Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 44 Spain Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 45 Spain Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 46 Asia Pacific Auto-injectors Market, by Country, 2015 - 2026 (USD Million)
Table 47 Asia Pacific Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 48 Asia Pacific Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 49 Asia Pacific Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 50 Asia Pacific Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 51 India Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 52 India Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 53 India Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 54 India Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 55 Japan Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 56 Japan Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 57 Japan Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 58 Japan Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 59 China Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 60 China Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 61 China Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 62 China Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 63 Australia Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 64 Australia Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 65 Australia Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 66 Australia Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 67 South Korea Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 68 South Korea Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 69 South Korea Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 70 South Korea Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 71 Latin America Auto-injectors Market, by Country, 2015 - 2026 (USD Million)
Table 72 Latin America Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 73 Latin America Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 74 Latin America Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 75 Latin America Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 76 Brazil Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 77 Brazil Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 78 Brazil Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 79 Brazil Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 80 Mexico Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 81 Mexico Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 82 Mexico Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 83 Mexico Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 84 Argentina Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 85 Argentina Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 86 Argentina Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 87 Argentina Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 88 Colombia Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 89 Colombia Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 90 Colombia Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 91 Colombia Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 92 MEA Auto-injectors Market, by Country, 2015 - 2026 (USD Million)
Table 93 MEA Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 94 MEA Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 95 MEA Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 96 MEA Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 97 South Africa Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 98 South Africa Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 99 South Africa Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 100 South Africa Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 101 Saudi Arabia Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 102 Saudi Arabia Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 103 Saudi Arabia Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 104 Saudi Arabia Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)
Table 105 UAE Auto-injectors Market, by Disease Indication, 2015 - 2026 (USD Million)
Table 106 UAE Auto-injectors Market, by Product Type, 2015 - 2026 (USD Million)
Table 107 UAE Auto-injectors Market, by Reusable auto-injectors, 2015 - 2026 (USD Million)
Table 108 UAE Auto-injectors Market, by End Use, 2015 - 2026 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Auto-injectors market: Market snapshot
Fig. 9 Auto-injectors market: Market segmentation
Fig. 10 Auto-injectors Market strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Auto-injectors market driver impact
Fig. 14 Auto-injectors market restraint impact
Fig. 15 Auto-injectors market Porter's five forces analysis
Fig. 16 Auto-injectors market PESTEL analysis
Fig. 17 Auto-injectors market segment dashboard
Fig. 18 Auto-injectors market: product type movement Analysis
Fig. 19 Disposable auto-injectors market estimates and forecast, 2015 - 2026
Fig. 20 Reusable auto-injectors market estimates and forecast, 2015 - 2026
Fig. 21 Prefilled auto-injectors market estimates and forecast, 2015 - 2026
Fig. 22 Empty auto-injectors market estimates and forecast, 2015 - 2026
Fig. 23 Auto-injectors market: Segment dashboard
Fig. 24 Auto-injectors market: Disease indication movement analysis
Fig. 25 Rheumatoid arthritis market estimates and forecast, 2015 - 2026
Fig. 26 Multiple sclerosis market estimates and forecast, 2015 - 2026
Fig. 27 Diabetes market estimates and forecast, 2015 - 2026
Fig. 28 Anaphylaxis market estimates and forecast, 2015 - 2026
Fig. 29 Other Therapies market estimates and forecast, 2015 - 2026
Fig. 30 Auto-injectors market: Segment dashboard
Fig. 31 Auto-injectors market: End-use movement analysis
Fig. 32 Homecare settings market estimates and forecast, 2015 - 2026
Fig. 33 Hospitals & clinics market estimates and forecast, 2015 - 2026
Fig. 34 Ambulatory surgical centers market estimates and forecast, 2015 - 2026
Fig. 35 Global auto-injectors market: Regional movement analysis
Fig. 36 Global auto-injectors market: Regional outlook and key takeaways
Fig. 37 Global market share, by region
Fig. 38 North America auto-injectors market estimates and forecast, 2015 - 2026
Fig. 39 U.S. auto-injectors market estimates and forecast, 2015 - 2026
Fig. 40 Canada auto-injectors market estimates and forecast, 2015 - 2026
Fig. 41 Europe auto-injectors market estimates and forecast, 2015 - 2026
Fig. 42 U.K. auto-injectors market estimates and forecast, 2015 - 2026
Fig. 43 Germany auto-injectors market estimates and forecast, 2015 - 2026
Fig. 44 France auto-injectors market estimates and forecast, 2015 - 2026
Fig. 45 Italy auto-injectors market estimates and forecast, 2015 - 2026
Fig. 46 Spain auto-injectors market estimates and forecast, 2015 - 2026
Fig. 47 Asia Pacific auto-injectors market estimates and forecast, 2015 - 2026
Fig. 48 China auto-injectors market estimates and forecast, 2015 - 2026
Fig. 49 Japan auto-injectors market estimates and forecast, 2015 - 2026
Fig. 50 India auto-injectors market estimates and forecast, 2015 - 2026
Fig. 51 Australia auto-injectors market estimates and forecast, 2015 - 2026
Fig. 52 South Korea auto-injectors market estimates and forecast, 2015 - 2026
Fig. 53 Latin America auto-injectors market estimates and forecast, 2015 - 2026
Fig. 54 Brazil auto-injectors market estimates and forecast, 2015 - 2026
Fig. 55 Mexico auto-injectors market estimates and forecast, 2015 - 2026
Fig. 56 Argentina auto-injectors market estimates and forecast, 2015 - 2026
Fig. 57 Colombia auto-injectors market estimates and forecast, 2015 - 2026
Fig. 58 Middle East and Africa auto-injectors market estimates and forecast, 2015 - 2026
Fig. 59 South Africa auto-injectors market estimates and forecast, 2015 - 2026
Fig. 60 Saudi Arabia auto-injectors market estimates and forecast, 2015 - 2026
Fig. 61 UAE auto-injectors market estimates and forecast, 2015 - 2026